Hospital pharmacists are increasingly being acknowledged for their work with cell and gene therapies, as well as advanced therapy medicinal products (ATMPs). However, there's a lack of systematic evidence showing how effective their role really is. Let's break down what they do and why it's importan
Imagine trying to fight a bad guy (like cancer) but not having enough soldiers (immune cells) to help. That’s where interferon gamma (IFNγ) comes in. This tiny protein wakes up immune cells so they can fight invaders or even cancer cells. Scientists wanted to make a super vaccine for colon cancer, s
Ever thought about using scents to ease pain after surgery? Researchers decided to check if aromatherapy could help in the recovery room. The postanesthesia care unit, or PACU, is where patients wake up from surgery. It can be a rough time, with lots of pain. So, scientists looked into studies to se
Cri du Chat Syndrome (CdCS) is a rare condition caused by a missing piece on chromosome 5. This often leads to troubles with swallowing, talking, moving, and thinking clearly. Kids with CdCS have odd larynxes and struggle with mouth movements. This study explored how speech therapy could help fix th
Treatment options for epithelial ovarian cancer (EOC) have expanded a lot in recent years, but much of the progress has been tied to picking the right biomarkers. This means there's still a big need for better treatment options to help patients live longer and enjoy better quality of life. Unlike ma
Imagine you're battling advanced biliary tract cancer (ABTC), and your doctors suggest a mix of drugs: nivolumab, modified gemcitabine, and S-1. This combo showed promise in a past trial, but PD-L1 levels didn't tell us much about how well it would work. So, scientists looked at another marker, LAG-
Immune treatments, or immune checkpoint inhibitors (ICIs), are game-changers for some people with far-advanced solid tumors. But when it comes to biliary tract cancer (BTC), doctors are still figuring out who gets the most benefit from these treatments. A recent trial focused on pembrolizumab, an IC
Biliary tract cancers, like cholangiocarcinoma and gallbladder cancer, are growing more common worldwide, and most patients get diagnosed when the disease has already advanced, leading to a grim outlook. Recently, combining immune checkpoint inhibitors, such as durvalumab and pembrolizumab, with the
Let's talk about intraocular inflammation (IOI) and its link to faricimab therapy. This medication is used to treat eye conditions, but like any treatment, it can have side effects. So, what did we learn from observing patients over a year in a big hospital? Researchers wanted to get real-world insi
Chronic obstructive pulmonary disease, or COPD, is often caused by smoking, but other factors like pollution and chemical exposure can also contribute. One common treatment for COPD is oxygen therapy, which helps ease breathing difficulty and boost survival rates. With advances in technology, mobile
